Our pursuit and company goal is to "Always satisfy our customer requirements". We continue to develop and design superior quality products for both our old and new customers and achieve a win-win prospect for our clients as well as us for Dc301 Factories, Low Copy Gene Amplification Suppliers, Phosphorylation Manufacturer,Best Capture Hybridization , Gelred Suppliers.We sincerely welcome friends from all over the world to cooperate with us on the basis of long-term mutual benefits. The product will supply to all over the world, such as Europe, America, Australia, Hyderabad ,Rome ,Sheffield ,They are sturdy modeling and promoting effectively all over the world. Never ever disappearing major functions within a quick time, it's a have to for you of fantastic good quality. Guided by the principle of Prudence, Efficiency, Union and Innovation. the corporation. ake an excellent efforts to expand its international trade, raise its organization. rofit and raise its export scale. We are confident that we are going to have a bright prospect and to be distributed all over the world in the years to come.
This kit is designed for the detection of host cell protein residues in process samples of biologics (such as antibodies, recombinant proteins, vaccines, etc.) expressed in CHO cell lines.
T7 RNA Polymerase (T7 RNA polymerase) is a DNA-dependent 5'→3' RNA polymerase that recognizes the T7 promoter sequence with high specificity ,can be used for transcriptional synthesis of mRNA in IVT.
The dsRNA sequence synthesized by UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
The dsRNA sequence synthesized by Pseudouridine-UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
The dsRNA sequence synthesized by N1-me-pseudo-UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
A next-generation T7 RNA polymerase engineered to minimize dsRNA byproducts by up to 100×, enabling safer and more efficient mRNA therapeutics.
